Skip to content
LexBuild

National Cancer Institute; Notice of Meeting

---
identifier: "/us/fr/01-1633"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "01-1633"
section_name: "National Cancer Institute; Notice of Meeting"
positive_law: false
currency: "2001-01-22"
last_updated: "2001-01-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-1633"
document_type: "notice"
publication_date: "2001-01-22"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "66 FR 6639"
fr_volume: 66
---

#  National Cancer Institute; Notice of Meeting

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

*Name of Committee:* National Cancer Institute Director's Consumer Liaison Group.

*Date:* January 29, 2001.

*Time:* 12:30 pm to 2:30 pm.

*Agenda:* To get updates from the working groups and to discuss the advocates section of the April 2001 DCLG meeting.

*Place:* National Cancer Institute, 6116 Executive Boulevard, Suite 300 C, Rockville, MD 20852, (Telephone Conference Call).

*Contact Person:* Elaine Lee, Acting Executive Secretary, Office of Liaison Activities, National Institute of Health, National Cancer Institute, 6116 Executive Boulevard, Suite 300 C, Bethesda, MD 20892, 301/594-3194.

This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 12, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.